Drug metabolism/pharmacokinetics and drug interaction studies have been extensively carried out in order to secure the druggability and safety of new chemical entities throughout the development of new drugs. Recently, drug metabolism and transport by phase II drug metabolizing enzymes and drug transporters, respectively, as well as phase I drug metabolizing enzymes, have been studied. A combination of biochemical advances in the function and regulation of drug metabolizing enzymes and automated analytical technologies are revolutionizing drug metabolism research. There are also potential drug–drug interactions with co-administered drugs due to inhibition and/or induction of drug metabolic enzymes and drug transporters. In addition, drug in...
The competition of two drugs for the same metabolizing enzyme is a common mechanism for drug–drug in...
During the process of drug discovery, the pharmaceutical industry is faced with numerous challenges....
Keywords: intensive care unit;drug–drug interaction;cytochrome P450;CYP3A4;enzymes;transporters;P-gp...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
Drug metabolism as a discipline plays an important role in drug discovery and development and the ef...
Pharmacokinetics (PK) is the study of the absorption, distribution, metabolism, and excretion (ADME)...
This book serves to highlight the pharmacokinetics/drug–drug interactions and mechanistic understand...
In order to avoid late-stage drug failure due to factors such as undesirable metabolic instability, ...
Drug-Drug interactions (DDI) is a serious clinical issue. An important mechanism underlying of DDI, ...
Drug-drug interactions (DDIs) occur when a patient's response to the drug is modified by administrat...
Includes bibliographical references and index.xviii, 746 pages :"Germination of the thought of ""Enz...
Pharmacokinetic drug-drug interactions (PDDI), in which the pharmacokinetic clearance of one drug is...
© 2017, Springer International Publishing Switzerland. Following the drug administration, patients a...
Many drug-drug interactions (DDIs) are based on alterations of the plasma concentrations of a victim...
rug interactions are the harmful or beneficial effects of co administered medicinal products, these ...
The competition of two drugs for the same metabolizing enzyme is a common mechanism for drug–drug in...
During the process of drug discovery, the pharmaceutical industry is faced with numerous challenges....
Keywords: intensive care unit;drug–drug interaction;cytochrome P450;CYP3A4;enzymes;transporters;P-gp...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
Drug metabolism as a discipline plays an important role in drug discovery and development and the ef...
Pharmacokinetics (PK) is the study of the absorption, distribution, metabolism, and excretion (ADME)...
This book serves to highlight the pharmacokinetics/drug–drug interactions and mechanistic understand...
In order to avoid late-stage drug failure due to factors such as undesirable metabolic instability, ...
Drug-Drug interactions (DDI) is a serious clinical issue. An important mechanism underlying of DDI, ...
Drug-drug interactions (DDIs) occur when a patient's response to the drug is modified by administrat...
Includes bibliographical references and index.xviii, 746 pages :"Germination of the thought of ""Enz...
Pharmacokinetic drug-drug interactions (PDDI), in which the pharmacokinetic clearance of one drug is...
© 2017, Springer International Publishing Switzerland. Following the drug administration, patients a...
Many drug-drug interactions (DDIs) are based on alterations of the plasma concentrations of a victim...
rug interactions are the harmful or beneficial effects of co administered medicinal products, these ...
The competition of two drugs for the same metabolizing enzyme is a common mechanism for drug–drug in...
During the process of drug discovery, the pharmaceutical industry is faced with numerous challenges....
Keywords: intensive care unit;drug–drug interaction;cytochrome P450;CYP3A4;enzymes;transporters;P-gp...